Among the topics Lu Rahman will be discussing with Wylie will be the key challenges scientists face with biomarker and drug discovery and how high-thr...
The Bamlanivimab story - how it reached clinic in eight months
Bamlanivimab was the first neutralising monoclonal antibody to receive emergency use authorisation from the FDA as a treatment for mild to moderate CO...
Recipe for success: collaboration in drug discovery
The latest free-to-listen DDW podcast episode is titled “Recipe for success: collaboration in drug discovery”. It covers three articles: “Why collab...
Opportunities to improve drug discovery systems
This is the latest episode of the free DDW podcast: “Opportunities to improve drug discovery systems”. It covers two articles written for Volume 22, ...
Putting virology back on the map: the fight against Covid-19
This is the latest episode of the free DDW podcast, “Putting virology back on the map: the fight against Covid-19”. It covers two articles written fo...
The benefits of robust colony management in drug discovery
John Couse, Vice President of Scientific Services at Taconic Biosciences discusses the benefits of a robust colony management solution/partner in the ...
Automating the cell culture workflow
In this podcast Dr. Joanna Hawryluk discusses automating the cell culture workflow and explains the importance of cell culture workflow in the drug di...
Streamlining gene therapy and how MS provides information on virus structure
This episode covers two narrated articles written for DDW and is read aloud by Megan Thomas, both of which were published in Volume 22, Issue 1 – Wint...
A model for successful pharma and vendor engagement
Digital transformations are having wide-ranging and profound impacts within life sciences, creating both opportunities and challenges. One of those ch...
Paving the way for optimum drug discovery
This is the latest episode of the free DDW podcast, “Paving the way for optimum drug discovery”. It covers two narrated articles written for Volume 22...